InsiderTrades.com logo
Did You See Trump’s Bombshell Exec. Order 001?
From Banyan Hill Publishing   |   Ad
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
I put all the details together for you here — but please hurry. 

CTCX Insider Trading

Insider Ownership Percentage: 29.00%
Insider Buying (Last 12 Months): $66,606.67
Insider Selling (Last 12 Months): $0.00

Carmell Insider Trading History Chart

This chart shows the insider buying and selling history at Carmell by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Carmell Share Price & Price History

Current Price: $0.22
Price Change: ▼ Price Decrease of -0.0017 (-0.77%)
As of 12/20/2024 06:40 PM ET

This chart shows the closing price history over time for CTCX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Most People Are Dead Wrong.
From Brownstone Research   |   Ad
Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.
I call it my AI Retirement Playbook. I recommend you check it out now.

Carmell Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2024Bryan J CassadayCFOBuy475$0.46$218.504,250View SEC Filing Icon  
9/6/2024Kathryn GregoryDirectorBuy1,260$0.51$642.6022,500View SEC Filing Icon  
8/30/2024Scott M FrischDirectorBuy87$0.57$49.596,589View SEC Filing Icon  
8/29/2024Bryan J CassadayCFOBuy1,000$0.57$570.003,775View SEC Filing Icon  
8/28/2024Patrick A SturgeonDirectorBuy970$0.56$543.2016,029View SEC Filing Icon  
8/26/2024Patrick A SturgeonDirectorBuy1,587$0.72$1,142.6413,472View SEC Filing Icon  
8/22/2024Kathryn GregoryDirectorBuy2,413$0.72$1,737.3612,156View SEC Filing Icon  
8/20/2024Richard A UptonDirectorBuy3,600$0.89$3,204.0010,000View SEC Filing Icon  
6/12/2024Richard A UptonDirectorBuy2,000$2.20$4,400.006,400View SEC Filing Icon  
6/10/2024Bryan J CassadayCFOBuy440$2.50$1,100.002,775View SEC Filing Icon  
6/6/2024Rajiv ShuklaCEOBuy2,100$2.63$5,523.0072,103View SEC Filing Icon  
5/30/2024Rajiv ShuklaCEOBuy2,000$2.50$5,000.0070,003View SEC Filing Icon  
5/29/2024Bryan J CassadayCFOBuy30$2.60$78.001,970View SEC Filing Icon  
5/28/2024Rajiv ShuklaCEOBuy20$2.57$51.4068,003View SEC Filing Icon  
5/24/2024Rajiv ShuklaCEOBuy1,939$2.57$4,983.2367,983View SEC Filing Icon  
5/22/2024Rajiv ShuklaCEOBuy4,051$2.41$9,762.9163,944View SEC Filing Icon  
5/20/2024Rajiv ShuklaCEOBuy1,172$2.22$2,601.8458,378View SEC Filing Icon  
4/4/2024Rajiv ShuklaCEOBuy8,680$2.88$24,998.4057,206View SEC Filing Icon  
12/14/2023Gilles SpenlehauerDirectorBuy313$3.61$1,129.934,790View SEC Filing Icon  
12/12/2023Richard A UptonDirectorBuy2,000$3.50$7,000.002,000View SEC Filing Icon  
12/7/2023Scott M FrischDirectorBuy199$3.07$610.931,833View SEC Filing Icon  
12/5/2023Scott M FrischDirectorBuy277$3.10$858.701,147View SEC Filing Icon  
11/30/2023Rajiv ShuklaCEOBuy5,600$2.66$14,896.0033,677View SEC Filing Icon  
11/28/2023Bryan J CassadayCFOBuy1,500$2.85$4,275.001,500View SEC Filing Icon  
11/27/2023Rajiv ShuklaCEOBuy2,100$2.97$6,237.0020,562View SEC Filing Icon  
11/24/2023Rajiv ShuklaCEOBuy2,715$2.95$8,009.2518,462View SEC Filing Icon  
11/22/2023Rajiv ShuklaCEOBuy1,185$2.78$3,294.3015,747View SEC Filing Icon  
11/20/2023Rajiv ShuklaCEOBuy3,750$2.62$9,825.0014,362View SEC Filing Icon  
11/17/2023Rajiv ShuklaCEOBuy2,000$2.69$5,380.0010,612View SEC Filing Icon  
8/28/2023Rajiv ShuklaChairmanBuy2,100$3.50$7,350.008,612View SEC Filing Icon  
8/28/2023Randolph W HubbellCEOBuy100$3.49$349.002,750View SEC Filing Icon  
8/25/2023Randolph W HubbellCEOBuy200$3.50$700.002,650View SEC Filing Icon  
8/24/2023Rajiv ShuklaChairmanBuy500$3.50$1,750.005,912View SEC Filing Icon  
8/23/2023Randolph W HubbellCEOBuy200$3.60$720.002,250View SEC Filing Icon  
8/21/2023Rajiv ShuklaChairmanBuy100$3.54$354.005,412View SEC Filing Icon  
8/21/2023Randolph W HubbellCEOBuy300$3.67$1,101.001,950View SEC Filing Icon  
8/18/2023Rajiv ShuklaChairmanBuy4,100$3.62$14,842.005,312View SEC Filing Icon  
8/17/2023Randolph W HubbellCEOBuy450$3.72$1,674.00450View SEC Filing Icon  
8/16/2023Rajiv ShuklaChairmanBuy1,112$3.74$4,158.881,112View SEC Filing Icon  
See Full Table
First JFK… next Elon?
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.

SEC Filings (Institutional Ownership Changes) for Carmell (NASDAQ:CTCX)

24.22% of Carmell stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CTCX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Carmell Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/9/2024Warberg Asset Management LLC45,000$60K0.0%N/A0.216%Search for SEC Filing on Google Icon
4/18/2024Hubbell Strickland Wealth Management LLC12,548$32K0.0%N/A0.065%Search for SEC Filing on Google Icon
11/15/2023Linden Advisors LP75,000$0.27M0.0%N/A0.390%Search for SEC Filing on Google Icon
11/14/2023Meteora Capital LLC1,780,919$6.42M1.1%N/A9.256%Search for SEC Filing on Google Icon
11/7/2023Cookson Peirce & Co. Inc.15,000$54K0.0%N/A0.078%Search for SEC Filing on Google Icon
11/1/2023Carnegie Mellon University103,061$0.37M0.5%N/A0.536%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Carmell logo
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.
Read More on Carmell

Today's Range

Now: $0.22
Low: $0.20
High: $0.23

50 Day Range

MA: $0.31
Low: $0.21
High: $0.63

52 Week Range

Now: $0.22
Low: $0.20
High: $4.31

Volume

1,253,869 shs

Average Volume

1,316,654 shs

Market Capitalization

$4.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.3

Who are the company insiders with the largest holdings of Carmell?

Carmell's top insider shareholders include:
  1. Rajiv Shukla (CEO)
  2. Kathryn Gregory (Director)
  3. Patrick A Sturgeon (Director)
  4. Richard A Upton (Director)
  5. Rajiv Shukla (Chairman)
  6. Scott M Frisch (Director)
  7. Gilles Spenlehauer (Director)
  8. Bryan J Cassaday (CFO)
  9. Randolph W Hubbell (CEO)
Learn More about top insider investors at Carmell.
Did You See Trump’s Bombshell Exec. Order 001?
From Banyan Hill Publishing   |   Ad
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
I put all the details together for you here — but please hurry.